5Chandran G,Seshadri P,Ahern J,et al.Rheumatic manifestaions of the myelodyspastic syndromes:a comparative study[J].Aust N Z J Med,1996,26:683-685.
6Mediwake R, Isenberg DA, Schellekens GA. Use of anticitrullianted peptide and-RA33 antibodies in distinguish erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis, 2001,60(1) : 67--78.
7Bizzaro N, Mazzanti G, Tonutti E. Diagnostic accuracy of the anticitrulline antibody assay for rheumatoid arthritis. Clin Chem, 2001, 47(6) : 1089--96.
8Ostergaaard M, Hansen M, Stolrnberg M, et al. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum, 1999, 42(5) :918--27.
10Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988,31:315-324.
